| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.065 | 0.3 |